No abstract available
MeSH terms
-
Administration, Intravenous
-
Adrenergic beta-Antagonists / administration & dosage
-
Adrenergic beta-Antagonists / therapeutic use
-
Amphetamine-Related Disorders / complications
-
Anti-Anxiety Agents / administration & dosage
-
Anti-Anxiety Agents / adverse effects
-
Anti-Anxiety Agents / therapeutic use
-
Anxiety / chemically induced
-
Anxiety / drug therapy
-
Cardiovascular Diseases / chemically induced*
-
Cardiovascular Diseases / diagnosis
-
Cardiovascular Diseases / drug therapy
-
Cardiovascular System / drug effects*
-
Central Nervous System Stimulants / pharmacology
-
Central Nervous System Stimulants / toxicity
-
Chest Pain / chemically induced
-
Chest Pain / diagnosis
-
Cocaine / toxicity*
-
Cocaine-Related Disorders / complications
-
Drug Interactions
-
Electrocardiography
-
Humans
-
Hyperhidrosis / chemically induced
-
Hyperhidrosis / drug therapy
-
Labetalol / administration & dosage*
-
Labetalol / therapeutic use
-
Lorazepam / administration & dosage*
-
Lorazepam / adverse effects
-
Lorazepam / therapeutic use
-
Male
-
Methamphetamine / pharmacology
-
Methamphetamine / toxicity*
-
Sodium Chloride / administration & dosage
-
Sodium Chloride / therapeutic use
-
Tachycardia / chemically induced
-
Tachycardia / diagnosis
-
Young Adult
Substances
-
Adrenergic beta-Antagonists
-
Anti-Anxiety Agents
-
Central Nervous System Stimulants
-
Methamphetamine
-
Sodium Chloride
-
Cocaine
-
Lorazepam
-
Labetalol